MONTGOMERY, Texas--(BUSINESS WIRE)--Metabolic Research, Inc. (OTC BB: MTBR) is pleased to announce a well-respected firm, TRI-STATE Capital (TSC), has upgraded their equity rating on MTBR. This strong upgrade is due to the company’s license to develop effective, non-toxic, anti-inflammatory natural drugs aimed at treating arthritis and the company’s recent strategic alliance with Partners In Science Holdings, Inc. ("PISH"). Pursuant to the strategic alliance agreement between MTBR and PISH, both companies will include the other party's products into its marketing and distribution channels. One of the significant products in development by PISH is aimed at treating cancer. The strong upgrade is also due to the company’s experienced executive team in the area of medical research.
